346 related articles for article (PubMed ID: 30790462)
1. The Case for Proteomics and Phospho-Proteomics in Personalized Cancer Medicine.
Doll S; Gnad F; Mann M
Proteomics Clin Appl; 2019 Mar; 13(2):e1800113. PubMed ID: 30790462
[TBL] [Abstract][Full Text] [Related]
2. Proteomics and phosphoproteomics in precision medicine: applications and challenges.
Giudice G; Petsalaki E
Brief Bioinform; 2019 May; 20(3):767-777. PubMed ID: 29077858
[TBL] [Abstract][Full Text] [Related]
3. Phosphoproteome and Proteome Sample Preparation from Mouse Tissues for Circadian Analysis.
Brüning F; Humphrey SJ; Robles MS
Methods Mol Biol; 2021; 2130():185-193. PubMed ID: 33284445
[TBL] [Abstract][Full Text] [Related]
4. Personalization of prostate cancer therapy through phosphoproteomics.
Yang W; Freeman MR; Kyprianou N
Nat Rev Urol; 2018 Aug; 15(8):483-497. PubMed ID: 29752463
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas.
Fordham AM; Ekert PG; Fleuren EDG
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188613. PubMed ID: 34390800
[TBL] [Abstract][Full Text] [Related]
6. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
7. Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska A; Frantzi M; Vlahou A; Merseburger AS; Mischak H
Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 28980455
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry based proteomics and metabolomics in personalized oncology.
Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
[TBL] [Abstract][Full Text] [Related]
9. Role of phosphoproteomics in the development of personalized cancer therapies.
Cutillas PR
Proteomics Clin Appl; 2015 Apr; 9(3-4):383-95. PubMed ID: 25488289
[TBL] [Abstract][Full Text] [Related]
10. Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection.
Labots M; van der Mijn JC; Beekhof R; Piersma SR; de Goeij-de Haas RR; Pham TV; Knol JC; Dekker H; van Grieken NCT; Verheul HMW; Jiménez CR
J Proteomics; 2017 Jun; 162():99-107. PubMed ID: 28442448
[TBL] [Abstract][Full Text] [Related]
11. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
12. Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment.
Haga Y; Minegishi Y; Ueda K
Cancer Sci; 2023 May; 114(5):1783-1791. PubMed ID: 36661476
[TBL] [Abstract][Full Text] [Related]
13. Implementation of Clinical Phosphoproteomics and Proteomics for Personalized Medicine.
Casado P; Hijazi M; Gerdes H; Cutillas PR
Methods Mol Biol; 2022; 2420():87-106. PubMed ID: 34905168
[TBL] [Abstract][Full Text] [Related]
14. Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities.
Padhye BD; Nawaz U; Hains PG; Reddel RR; Robinson PJ; Zhong Q; Poulos RC
Pediatr Blood Cancer; 2024 Jun; 71(6):e30980. PubMed ID: 38556739
[TBL] [Abstract][Full Text] [Related]
15. Proteomics-based interrogation of the kinome and its implications for precision oncology.
Lim Kam Sian TCC; Chüeh AC; Daly RJ
Proteomics; 2021 Sep; 21(17-18):e2000161. PubMed ID: 33547865
[TBL] [Abstract][Full Text] [Related]
16. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
17. Advancing translational research and precision medicine with targeted proteomics.
Uzozie AC; Aebersold R
J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
[TBL] [Abstract][Full Text] [Related]
18. Proteomic developments in the analysis of formalin-fixed tissue.
Gustafsson OJ; Arentz G; Hoffmann P
Biochim Biophys Acta; 2015 Jun; 1854(6):559-80. PubMed ID: 25315853
[TBL] [Abstract][Full Text] [Related]
19. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology.
Krasny L; Huang PH
Mol Omics; 2021 Feb; 17(1):29-42. PubMed ID: 33034323
[TBL] [Abstract][Full Text] [Related]
20. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
Ciocan-Cartita CA; Jurj A; Buse M; Gulei D; Braicu C; Raduly L; Cojocneanu R; Pruteanu LL; Iuga CA; Coza O; Berindan-Neagoe I
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]